CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Simpson Curran Chief Executive Officer | Shares withheld for taxes | −6,818 | $13.09 | $89K | 338,053 |
| 2026-06-30 | Simpson Curran Chief Executive Officer | Grant or award | +1,453 | $10.18 | $15K | 344,871 |
| 2026-01-06 | Simpson Curran Chief Executive Officer | Grant or award | +144,864 | 342,467 | ||
| 2026-01-06 | Simpson Curran Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +233,651 | 233,651 | ||
| 2026-01-02 | Simpson Curran Chief Executive Officer | Shares withheld for taxes | −18,559 | $14.40 | $267K | 197,603 |
| 2025-12-31 | Simpson Curran Chief Executive Officer | Grant or award | +951 | $7.00 | $7K | 343,418 |
| 2025-10-09 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −20,811 | $12.62 | $263K | 216,162 |
| 2025-09-29 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −7,624 | $10.03 | $76K | 236,973 |
| 2025-09-10 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −7,734 | $10.02 | $77K | 244,597 |
| 2025-07-01 | Simpson Curran Chief Executive Officer | Shares withheld for taxes | −4,701 | $8.23 | $39K | 252,331 |
| 2025-01-02 | Simpson Curran Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +478,606 | 478,606 | ||
| 2025-01-02 | Simpson Curran Chief Executive Officer | Shares withheld for taxes | −11,917 | $7.73 | $92K | 158,120 |
| 2025-01-02 | Simpson Curran Chief Executive Officer | Grant or award | +98,912 | 257,032 | ||
| 2025-01-02 | Simpson Curran Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +476,606 | 476,606 | ||
| 2024-08-01 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −100 | $15.00 | $2K | 170,037 |
| 2024-07-29 | Simpson Curran Chief Executive Officer | Sale 10b5-1 | −9,648 | $15.04 | $145K | 170,137 |
| 2024-07-01 | Simpson Curran Chief Executive Officer | Grant or award | +56,458 | 179,785 | ||
| 2024-07-01 | Simpson Curran Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +272,189 | 272,189 | ||
| 2024-01-02 | Simpson Curran Chief Oper. & Tech. Officer | Shares withheld for taxes | −8,120 | $17.95 | $146K | 84,865 |
| 2024-01-02 | Simpson Curran Chief Oper. & Tech. Officer | Grant or award | +38,462 | 123,327 |
Page 1 of 6 · 104 trades